Citation:Russo A, Rizzo S, Fulfaro F, Adamo V, Santini D, Vincenzi B, et al 2009

From Cancer Guidelines Wiki

Citation


Russo A, Rizzo S, Fulfaro F, Adamo V, Santini D, Vincenzi B, et al. Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. Cancer 2009 May 1;115(9):1924-31 Available from: http://www.ncbi.nlm.nih.gov/pubmed/19235250.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Russo A, Rizzo S, Fulfaro F, Adamo V, Santini D, Vincenzi B, et al 2009What is the optimal systemic therapy for stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted
Russo A, Rizzo S, Fulfaro F, Adamo V, Santini D, Vincenzi B, et al 2009 2Is monotherapy with new third generation (3G) agents as effective as platinum combination therapy for treatment of stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted
Russo A, Rizzo S, Fulfaro F, Adamo V, Santini D, Vincenzi B, et al 2009 3What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Is monotherapy with new third generation (3G) agents as effective as platinum combination therapy for treatment of stage IV inoperable NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Is monotherapy with new third generation (3G) agents as effective as platinum combination therapy for treatment of stage IV inoperable NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the optimal systemic therapy for stage IV inoperable NSCLC?
  2. What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Russo_A,_Rizzo_S,_Fulfaro_F,_Adamo_V,_Santini_D,_Vincenzi_B,_et_al_2009&oldid=21669"